Stay updated on Imatinib in Acute Ischaemic Stroke Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Acute Ischaemic Stroke Clinical Trial page.

Latest updates to the Imatinib in Acute Ischaemic Stroke Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter was updated to Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated to v3.3.2. Previous revision v3.2.0 has been removed.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedNo additions or deletions are visible on the Study Details page for NCT03639922 (Imatinib in Acute Ischaemic Stroke). The content and structure appear unchanged.SummaryDifference0.3%

- Check93 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3%

- Check100 days agoChange Detected- Added numerous new contact email addresses and a new revision tag (v3.1.0). - Removed several MedlinePlus topics related to drug safety and a previous revision tag (v3.0.2).SummaryDifference0.5%

Stay in the know with updates to Imatinib in Acute Ischaemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Acute Ischaemic Stroke Clinical Trial page.